Clinical trial
The Role of Pioglitazone in Vascular Transcriptional Remodeling in Individuals Undergoing Coronary Artery Bypass Grafting
NCT05775380 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Pioglitazone in Vascular Transcriptional Remodeling in Individuals Undergoing Coronary Artery Bypass Grafting
- Lead sponsor
- University of Campinas, Brazil
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 15, 2023
- Completion date
- December 22, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.